Bristol-Myers Squibb Company
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.3% | +4.1% | -4.4% | -1.0% | -1.1% | -0.2% | +2.4% | +2.3% | -7.1% | -4.0% | +1.3% | |
| – | +15.0% | -9.8% | -6.2% | +4.4% | +6.1% | +3.4% | +7.9% | +7.2% | -17.5% | -7.4% | +5.0% | |
| – | +52.6% | -18.6% | -32.6% | +25.4% | +31.1% | +5.1% | +15.9% | +24.8% | -35.1% | -6.2% | -8.9% | |
| – | +59.8% | -21.3% | -31.2% | +21.7% | +34.2% | +8.5% | +15.5% | +21.3% | -35.3% | -1.8% | +5.5% | |
| – | -2.4% | -7.9% | +7.7% | -1.7% | -3.2% | +1.1% | +3.5% | -3.2% | -0.6% | -16.8% | -12.7% | |
| – | +9.3% | +12.1% | +3.1% | +8.3% | -23.3% | +4.3% | +2.7% | +0.8% | -2.5% | +2.5% | -0.7% | |
| – | -15.3% | +1.6% | – | – | +1.3% | +0.8% | +2.6% | +3.5% | +1.9% | – | – | |
| – | +0.1% | +2.7% | 0.0% | +0.1% | -0.1% | +0.1% | +0.2% | -0.1% | +0.0% | -0.1% | +0.0% | |
| – | -6.4% | +20.7% | -10.0% | -8.4% | -13.5% | -3.6% | -5.0% | -5.5% | -5.4% | -4.4% | -6.0% | |
| – | +5.6% | +25.6% | -5.9% | -1.4% | -0.3% | -1.6% | +2.9% | +1.4% | -8.6% | -7.2% | -1.6% | |
| – | -5.1% | +16.0% | -9.9% | -2.7% | +5.0% | +1.2% | +14.4% | +2.2% | -16.8% | -18.2% | -2.6% | |
| – | -41.6% | +93.8% | -41.7% | -66.5% | +79.2% | +67.3% | +31.7% | -3.8% | -47.9% | +1.7% | -59.0% | |
| – | +15.9% | +8.6% | +6.0% | -7.5% | +3.8% | +11.1% | +35.6% | -21.0% | -16.6% | +18.4% | -1.8% | |
| – | +14.1% | +35.0% | -1.3% | -0.4% | -2.2% | -3.0% | -3.7% | 0.0% | -3.6% | -1.6% | -0.1% | |
| – | +1.5% | -44.0% | +3.2% | +0.7% | -4.7% | +6.5% | +0.3% | +6.4% | -0.4% | +8.6% | +11.2% | |
| – | +1.9% | -45.6% | +3.0% | 0.0% | -7.4% | +8.0% | +0.3% | +5.8% | -1.2% | +8.2% | +11.1% | |
| – | -1.5% | -0.5% | +0.3% | +0.1% | +0.3% | +0.0% | +0.0% | 0.0% | +0.1% | +0.1% | +0.2% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.